Clinical/scientific notes

Neurology

Volumn 80, Issue 8, 2013, Pages 773-774

  Phillips, Lauren ^a   Singer, Mike A ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; GADOLINIUM; ANTIOBESITY AGENT;

ADULT; ANAMNESIS; CASE REPORT; ELECTROMYOGRAM; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; WEIGHT REDUCTION; ARTICLE; CHEMICALLY INDUCED DISORDER;

2,4-DINITROPHENOL; ANTI-OBESITY AGENTS; FEMALE; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES; YOUNG ADULT;

MLCS; MLOWN;

EID: 84876255659     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182825367     Document Type: Note

References (7)

1. Colman E. Dinitrophenol and obesity: an early twentieth-century regulatory dilemma. Regul Toxicol Pharmacol 2007;48:115-117.
2. Miranda EJ, McIntyre IM, Parker DR, Gary RD, Logan BK. Two deaths attributed to the use of 2,4-dinitrophenol. J Anal Toxicol 2006;30:219-222.
3. Bartlett J, Brunner M, Gough K. Deliberate poisoning with dinitrophenol (DNP): an unlicensed weight loss pill. Emerg Med J 2010;27:159-160.
4. Cutting WC, Mehrtens HG, Tainter ML. Actions and uses of dinitrophenol: promising metabolic applications. JAMA 1933;101:193-195.
5. Epstein E, Rosenblum H. Peripheral neuropathy and abortion following dinitrophenol therapy: report of a case. J Lab Clin Med 1935;20:1118-1121.
6. Lin CS, Krishnan AV, Lee MJ, et al. Nerve function and dysfunction in acute intermittent porphyria. Brain 2008; 131:2510-2519.
7. Tewari A, Ali T, O'Donnell J, Butt MS. Weight loss and 2,4-dinitrophenol poisoning. Br J Anaesth 2009;102: 566-567.